Results for: cancer screening

Thermography is Not Approved for Breast Cancer Screening in Canada

Breast cancer thermography is being promoted across Canada as a reliable and effective way of identifying breast tumors. There is no evidence thermography is actually capable of doing so.

/ October 12, 2018

“Liquid biopsies” for cancer screening: Life-saving tests, or overdiagnosis and overtreatment taken to a new level?

I’ve written many times about how the relationship between the early detection of cancer and decreased mortality from cancer is not nearly as straightforward as the average person—even the average doctor—thinks, the first time being in the very first year of this blog’s existence. Since then, the complexities and overpromising of various screening modalities designed to detect disease at an early, asymptomatic...

/ September 28, 2015

Recent Developments and Recurring Dilemmas in Cancer Screening: Colon, Lung, Thyroid

A new stool DNA test was recently approved by the FDA for colon cancer screening. My first reaction was “Yay! I hope it’s good enough to replace all those unpleasant, expensive screening colonoscopies.” But of course, things are never that simple. I wanted to explain the new test for our readers; but before I could start writing, some other issues in cancer...

/ November 18, 2014

Colonoscopy and Other Colorectal Cancer Screening Options: An Update

When I wrote about colonoscopy in 2010, colonoscopy was thought to be the best screening test for colorectal cancer because it could visualize the entire colon and could remove adenomas that were precursors of cancer. But only fecal occult blood testing (FOBT) and sigmoidoscopy had been proven to decrease colorectal cancer incidence and mortality (by 16% and 28%, respectively). Observational evidence suggested...

/ November 12, 2013

The USPSTF recommendations for breast cancer screening: Not the final word

Preface: On issues such as this, I think it’s always good for me to emphasize my disclaimer, in particular: Dr. Gorski must emphasize that the opinions expressed in his posts on Science-Based Medicine are his and his alone and that all writing for this blog is done on his own time and not in any capacity representing his place of employment. His...

/ November 18, 2009

The cancer screening kerfuffle erupts again: “Rethinking” screening for breast and prostate cancer

I see that the kerfuffle over screening for cancer has erupted again to the point where it’s found its way out of the rarified air of specialty journals to general medical journals and hence into the mainstream press. Over the last couple of weeks, articles have appeared in newspapers such as the New York Times and Chicago Tribune, radio networks like NPR,...

/ November 2, 2009

PSA Screening for Prostate Cancer

PSA testing is controversial. A new study finds that PSA screening for prostate cancer offers no survival benefits.

/ March 22, 2018

The ROCA Screening Test for Ovarian Cancer: Not Ready for Prime Time

Ovarian cancer is relatively rare but deadly. The lifetime risk of ovarian cancer is 1.5% compared to 12% for breast cancer, but it is the 5th most common cause of cancer death for women. Since the ovaries are hidden deep in the pelvis and the symptoms of ovarian cancer are non-specific, the cancer is often advanced by the time it is diagnosed...

/ June 21, 2016

Kidney Cancer and Incidentalomas

Kidney cancer diagnoses are increasing but there has been no increase in mortality or rate of metastases. Kidney cancer is most often diagnosed as an incidental finding on a CT scan that was done for unrelated reasons. Treatment may not always be needed.

/ February 12, 2019

Cancer Death Rate Continues to Decline

The new data are in – cancer deaths continue to decline at a steady rate.

/ January 9, 2019